Literature DB >> 6146266

Effects of beta-blockade on regional myocardial flow and function during exercise.

M Matsuzaki, J Patritti, T Tajimi, M Miller, W S Kemper, J Ross.   

Abstract

We examined the effects of a cardioselective beta-blocking drug on exercise-induced regional myocardial ischemia in 10 conscious dogs with chronic coronary artery stenosis. An ameroid constrictor, Doppler flowprobe, and hydraulic cuff were placed around the left circumflex coronary artery, and left ventricular pressure (LVP), systolic wall thickening (% delta WT; by sonomicrometry), and myocardial blood flow (MBF; microspheres) were measured during control standing, control treadmill exercise, and identical exercise after atenolol (1 mg/kg po). Prior to study, in every dog % delta WT and MBF in the ischemic area were normal at rest, indicating collateral development. During control exercise, % delta WT in the ischemic region markedly decreased from 27 to 4%, and transmural ischemia was evident in that region. Heart rate, systolic LVP, and LV (+)dP/dt were significantly lower during exercise after atenolol than during control exercise. % delta WT in the normal area was only 81% of that during control exercise, but dysfunction in the ischemic area was improved (77% increase compared with control exercise). Accompanying the improved function was a significant increase of MBF/beat and relative MBF in the ischemic zone; the endocardial-to-epicardial ratio increased from 0.27 to 0.47. Thus atenolol improved regional MBF distribution, thereby diminishing exercise-induced regional myocardial dysfunction and accelerating its recovery.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6146266     DOI: 10.1152/ajpheart.1984.247.1.H52

Source DB:  PubMed          Journal:  Am J Physiol        ISSN: 0002-9513


  22 in total

Review 1.  The relation of contractile function to myocardial perfusion. Perfusion-contraction match and mismatch.

Authors:  G Heusch; R Schulz
Journal:  Herz       Date:  1999-11       Impact factor: 1.443

Review 2.  The combination of slow-release nifedipine and atenolol for stable angina.

Authors:  D G Waller; V F Challenor
Journal:  Cardiovasc Drugs Ther       Date:  1990-08       Impact factor: 3.727

3.  Patient preparation for nuclear imaging: when should anti-ischemic medications be withheld?

Authors:  Sarkis B Baghdasarian; Gary V Heller
Journal:  J Nucl Cardiol       Date:  2007 Nov-Dec       Impact factor: 5.952

4.  The effects of beta1-adrenergic blockade on cardiovascular oxygen flow in normoxic and hypoxic humans at exercise.

Authors:  Guido Ferretti; Marc J Licker; Sara Anchisi; Christian Moia; Davide Susta; Denis R Morel
Journal:  Eur J Appl Physiol       Date:  2005-10-01       Impact factor: 3.078

5.  Pleiotropic, heart rate-independent cardioprotection by ivabradine.

Authors:  P Kleinbongard; N Gedik; P Witting; B Freedman; N Klöcker; G Heusch
Journal:  Br J Pharmacol       Date:  2015-07-21       Impact factor: 8.739

6.  Anti-inflammatory and pro-angiogenic effects of beta blockers in a canine model of chronic ischemic cardiomyopathy: comparison between carvedilol and metoprolol.

Authors:  D Elizabeth Le; Marco Pascotto; Howard Leong-Poi; Ibrahim Sari; Antonio Micari; Sanjiv Kaul
Journal:  Basic Res Cardiol       Date:  2013-09-27       Impact factor: 17.165

Review 7.  Neuronal control of coronary blood flow.

Authors:  D Baumgart; G Heusch
Journal:  Basic Res Cardiol       Date:  1995 Mar-Apr       Impact factor: 17.165

8.  Alpha 1-adrenergic blockade reduces exercise-induced regional myocardial ischemia in dogs.

Authors:  B D Guth; T Miura; E Thaulow; G Heusch; J Ross
Journal:  Basic Res Cardiol       Date:  1993 May-Jun       Impact factor: 17.165

9.  Persistence of regional left ventricular dysfunction after exercise-induced myocardial ischemia.

Authors:  D C Homans; E Sublett; X Z Dai; R J Bache
Journal:  J Clin Invest       Date:  1986-01       Impact factor: 14.808

Review 10.  The relationship between regional blood flow and contractile function in normal, ischemic, and reperfused myocardium.

Authors:  G Heusch
Journal:  Basic Res Cardiol       Date:  1991 May-Jun       Impact factor: 17.165

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.